Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 3 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Hepatitis C infection and advanced hepatocellular carcinoma-To treat or not to treat?
Cancer. 2022 Oct 1;128(19):3441-3442. doi: 10.1002/cncr.34408. Epub 2022 Aug 9.
Cancer. 2022.
PMID: 35942799
Free article.
No abstract available.
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma.
Parikh ND, Mehta N, Hoteit MA, Yang JD, John BV, Moon AM, Salgia RJ, Pillai A, Kassab I, Saeed N, Thyssen E, Nathani P, McKinney J, Chan W, Durkin C, Connor M, Alsudaney M, Konjeti R, Durand B, Nissen NN, Kim HP, Paknikar R, Rich NE, Schipper MJ, Singal AG.
Parikh ND, et al.
Cancer. 2022 Oct 1;128(19):3470-3478. doi: 10.1002/cncr.34378. Epub 2022 Jul 7.
Cancer. 2022.
PMID: 35796530
Free PMC article.
Item in Clipboard
Entecavir combined with interferon-α Is superior to entecavir monotherapy in reducing hepatic and extrahepatic cancer in patients with chronic hepatitis B.
Cheng K, Chen Y, Wang X, Xu M, Liao W, Duan X, Zhao X, Sun Y, Duan Z, Wang L.
Cheng K, et al.
Cancer. 2022 Feb 1;128(3):558-569. doi: 10.1002/cncr.33949. Epub 2021 Oct 8.
Cancer. 2022.
PMID: 34623636
Free article.
Item in Clipboard
Cite
Cite